Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

An interview with Laura Piddock - by Felicity Poole, commissioning editor .

Autor: Piddock L; Global Antibiotic R&D Partnership (GARDP), Geneva, Switzerland.

Publikováno v: Expert review of anti-infective therapy [Expert Rev Anti Infect Ther] 2023 May; Vol. 21 (5), pp. 491-493. Date of Electronic Publication: 2023 Jan 19.

Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings.

Autor: Darlow CA; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool L69 7BE, UK., McEntee L; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool L69 7BE, UK., Johnson A; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool L69 7BE, UK., Farrington N; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool L69 7BE, UK., Unsworth J; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool L69 7BE, UK., Jimenez-Valverde A; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool L69 7BE, UK., Jagota B; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool L69 7BE, UK., Kolamunnage-Dona R; Department of Health Data Science, University of Liverpool, Liverpool Health Partners, Liverpool L69 3GF, UK., Da Costa RMA; Global Antibiotic Research and Development Partnership, 15 Chemin Camille-Vidart, Geneva 1202, Switzerland., Ellis S; Global Antibiotic Research and Development Partnership, 15 Chemin Camille-Vidart, Geneva 1202, Switzerland., Franceschi F; Global Antibiotic Research and Development Partnership, 15 Chemin Camille-Vidart, Geneva 1202, Switzerland., Sharland M; Paediatric Infectious Diseases Research Group, St George's University of London, London SW17 0QT, UK., Neely M; Department of Infectious Diseases, Children's Hospital Los Angeles and the Keck School of Medicine, University of Southern California, Los Angeles, CA 90027, USA., Piddock L; Global Antibiotic Research and Development Partnership, 15 Chemin Camille-Vidart, Geneva 1202, Switzerland., Das S; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool L69 7BE, UK., Hope W; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool L69 7BE, UK.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2022 Nov 28; Vol. 77 (12), pp. 3349-3357.

Revitalizing the drug pipeline: AntibioticDB, an open access database to aid antibacterial research and development.

Autor: Farrell, L J, Lo, R, Wanford, J J, Jenkins, A, Maxwell, A, Piddock, L J V

Publikováno v: Journal of Antimicrobial Chemotherapy (JAC); Sep2018, Vol. 73 Issue 9, p2284-2297, 14p

Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance.

Autor: Darlow CA; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom., Docobo-Perez F; Departamento de Microbiología, Universidad de Sevilla, Seville, Spain., Farrington N; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom., Johnson A; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom., McEntee L; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom., Unsworth J; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom., Jimenez-Valverde A; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom., Gastine S; Great Ormond Street Institute of Child Health, University College London, London, United Kingdom., Kolamunnage-Dona R; Department of Health Data Science, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom., de Costa RMA; Global Antibiotic Research and Development Partnership, Geneva, Switzerland., Ellis S; Global Antibiotic Research and Development Partnership, Geneva, Switzerland., Franceschi F; Global Antibiotic Research and Development Partnership, Geneva, Switzerland., Standing JF; Great Ormond Street Institute of Child Health, University College London, London, United Kingdom., Sharland M; Paediatric Infectious Diseases Research Group, St. George's University of London, London, United Kingdom., Neely M; Children's Hospital Los Angeles and the Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Piddock L; Global Antibiotic Research and Development Partnership, Geneva, Switzerland.; Antimicrobials Research Group, School of Immunity and Infection, Institute for Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom., Das S; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom., Hope W; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Jun 17; Vol. 65 (7), pp. e0029321. Date of Electronic Publication: 2021 Jun 17.